COMMUNIQUÉS West-GlobeNewswire

Breathtec Biomedical Unaware of Any Material Change

09/01/2018 - 04:43

VANCOUVER, British Columbia, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Breathtec Biomedical, Inc. (CSE:BTH) (OTCQB:BTHCF) (the “ Company ” or “ Breathtec ”) - at the request of the Investment Industry Regulatory Organization of [...]

Quotient Limited Reports Further Positive Data on its Initial Disease Screening Microarray and Provides Update on Blood Grouping

09/01/2018 - 02:15

Performance evaluation studies for the initial disease screening microarray demonstrate 100% sensitivity and >99% specificity for the CMV and Syphilis assays V&V for blood grouping is ongoing – pending a [...]

Cannabis Wheaton Income Corp. Announces Increase of Previously Announced Private Placement Financing of Convertible Debenture Units to up to $100 Million

09/01/2018 - 00:12

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION TO UNITED STATES VANCOUVER, British Columbia, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V: [...]

BioSyent Announces Changes to Its Board of Directors

09/01/2018 - 00:09

TORONTO, Jan. 08, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”) (TSX Venture:RX) today announced the retirement of two long-serving Directors, Mr. Douglas Larson and Mr. Milton Wakefield, from its Board of [...]

Compass Cannabis Clinics and Starbuds Announce Canadian Joint Venture

08/01/2018 - 23:58

CALGARY, Alberta, Jan. 08, 2018 (GLOBE NEWSWIRE) -- 10330698 Canada Ltd. (dba Compass Cannabis Clinics (" Compass Cannabis " or the " Company ")) is pleased to announce that it has signed a binding letter agreement with [...]

Adamas Announces U.S. Commercial Launch of GOCOVRI™ the First and Only FDA-approved Medication for the Treatment of Dyskinesia in Parkinson’s Disease Patients

08/01/2018 - 22:41

EMERYVILLE, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced the full commercial launch of its flagship product, GOCOVRI™ (amantadine) extended release capsules, for [...]

ConforMIS Reports Preliminary Fourth Quarter and Year-End 2017 Revenue Results; Provides 2018 Financial Guidance

08/01/2018 - 22:15

BILLERICA, Mass., Jan. 08, 2018 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ: CFMS ), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell [...]

Tabula Rasa HealthCare to Participate in the 20th Annual Needham Growth Conference

08/01/2018 - 21:00

MOORESTOWN, N.J., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC ), a healthcare technology company optimizing medication safety by deploying new medication risk mitigation digital [...]

Sarepta Therapeutics Pre-Announces Fourth Quarter 2017 Revenue and Provides Full-Year 2018 Revenue Guidance for EXONDYS 51® (eteplirsen), Representing Approximately 100 Percent Year-over-Year Growth

08/01/2018 - 19:42

-- Fourth quarter 2017 EXONDYS 51 unaudited revenue of $57.3 million -- -- Full-year 2017 EXONDYS 51 unaudited revenue of $154.6 million -- -- Full-year 2018 EXONDYS 51 revenue guidance of $295 – $305 million -- -- 16 [...]

Vaccinex, Inc. Announces Research Collaboration Employing ActivMAb® Platform Technology and Antibody License Option Agreement with Surface Oncology

08/01/2018 - 19:10

ROCHESTER, N.Y., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Vaccinex, Inc., a privately-held clinical-stage biotechnology company engaged in the development of therapeutic monoclonal antibodies to treat patients with cancer and [...]

I-MED Pharma partners with OCuSOFT to bring the I-PEN® Osmolarity System to the U.S.A.

08/01/2018 - 19:02

MONTREAL, Jan. 08, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of an exclusive agreement with OCuSOFT Inc. for [...]

Nuvectra™ Announces Preliminary Unaudited Fourth Quarter and Full Year 2017 Revenue

08/01/2018 - 14:00

PLANO, Texas, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR ), a neurostimulation medical device company, today announced preliminary unaudited revenue for the fourth quarter and full year ended [...]

Teladoc Completes Record Visit Volume in 2017; Provides Preliminary Unaudited 2017 Results and 2018 Financial Outlook

08/01/2018 - 14:00

PURCHASE, NY, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Teladoc , Inc. (NYSE: TDOC ), today announced certain preliminary unaudited 2017 results and financial outlook for 2018. “For Teladoc, 2017 marked a landmark year as we [...]

Establishment Labs Appoints Dennis Condon to the Board of Directors

08/01/2018 - 18:22

NEW YORK, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Establishment Labs, a global medical device company focused on breast aesthetics and reconstruction technologies with a strong emphasis on product development and innovation, [...]

GUERBET : Guerbet announces its acquisition of Accurate Medical Therapeutics, an innovative company that develops microcatheters for interventional radiology

08/01/2018 - 18:12

Acceleration of the interventional radiology strategy Acquisition of a unique technology for image-guided embolization procedures Villepinte (France), January 8, 2018 (17:45 CET) - Guerbet (FR0000032526 GBT), a global [...]

GUERBET : Guerbet annonce l'acquisition d'Accurate Medical Therapeutics, société innovante dans les microcathéters pour la radiologie interventionnelle

08/01/2018 - 18:12

Accélération de la stratégie en radiologie interventionnelle Acquisition d'une technologie unique pour les procédures d'embolisation guidées par l'image Villepinte (France), le 8 janvier 2018 (17h45 heures CET) - [...]

ABLYNX ANNOUNCES BOARD CHANGES

08/01/2018 - 17:32

8 January 2018 - 5:30 pm CET GHENT, Belgium, 8 January 2018 (5:30 pm CET) - Ablynx NV [Euronext Brussels and Nasdaq: ABLX] today announced that Dr Peter Fellner, who has served as Chairman since 2013 [1] , has decided [...]

Ossur Hf : Transactions in relation to share buyback program

08/01/2018 - 17:01

Announcement from Össur hf. No. 2/2018 Reykjavík, 8 January 2018 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program is to [...]

Stratos Genomics Raises Funds to Ready for Commercialization

08/01/2018 - 16:00

SEATTLE, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Stratos Genomics, Inc. , a 4th generation DNA sequencing technology company, today announced it has raised $20 million in venture capital from Fisk Ventures. The funds will be [...]